首页> 美国卫生研究院文献>Gastroenterology Report >Sphincteroplasty for anal incontinence
【2h】

Sphincteroplasty for anal incontinence

机译:括约肌成形术治疗肛门失禁

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sphincteroplasty (SP) is the operation most frequently performed in patients suffering from moderate-to-severe anal incontinence (AI) who do not respond to conservative treatment. Other costly surgeries, such as artificial bowel sphincter (ABS) and electro-stimulated graciloplasty, have been more or less abandoned due to their high morbidity rate. Minimally invasive procedures are widely used, such as sacral neuromodulation and injection of bulking agents, but both are costly and the latter may cure only mild incontinence. The early outcome of SP is usually good if the sphincters are not markedly denervated, but its effect diminishes over time. SP is more often performed for post-traumatic than for idiopathic AI. It may also be associated to the Altemeier procedure, aimed at reducing the recurrence rate of rectal prolapse, and may be useful when AI is due either to injury to the sphincter, or to a narrowed rectum following the procedure for prolapse and haemorrhoids (PPH) and stapled transanal rectal resection (STARR). The outcome of SP is likely to be improved with biological meshes and post-operative pelvic floor rehabilitation. SP is more effective in males than in multiparous women, whose sphincters are often denervated, and its post-operative morbidity is low. In conclusion, SP, being both low-cost and safe, remains a good option in the treatment of selected patients with AI.
机译:括约肌成形术(SP)是患有中度至重度肛门失禁(AI)且对保守治疗无反应的患者中最常进行的手术。其他昂贵的手术,例如人工肠括约肌(ABS)和电刺激的晶状体成形术,由于其高发病率而已或多或少被放弃。微创手术已被广泛使用,例如神经调节和填充剂的注射,但两者都很昂贵,后者只能治愈轻度失禁。如果括约肌没有明显失神经,SP的早期结果通常是好的,但是随着时间的流逝其作用会减弱。 SP对于创伤后患者比对特发性AI更常进行。它也可能与Altemeier手术有关,旨在降低直肠脱垂的复发率,并且当AI是由于括约肌的损伤或由于脱垂和痔疮(PPH)手术后直肠变窄而引起的时可能有用并经吻合肛门直肠切除术(STARR)。 SP的结果可能通过生物网片和术后骨盆底修复得到改善。 SP在男性中比在子宫中的括约肌通常失神经的多产女性中更有效,并且其术后发病率较低。总而言之,SP既便宜又安全,在选择AI的患者中仍然是一个不错的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号